News
PraxisUnico joins forces with partners to support emerging healthcare businesses
18 January 2012
Cambridge, UK, 18 January 2012 – PraxisUnico, the leading research commercialisation body, has joined forces with Stevenage Bioscience Catalyst (SBC) - the UK’s first open innovation bioscience campus – and the Technology Strategy Board to deliver a seminar and networking forum to give aspiring entrepreneurs and young healthcare businesses an insight into how to start-up, fund and grow innovative new companies.
PraxisUnico responds to Innovation and Research Strategy for Growth
9 December 2011
PraxisUnico responds to Department of Business Innovation and Skills, Innovation and Research Strategy for Growth
PraxisUnico: Congratulations on new roles for committee members
18 November 2011
PraxisUnico congratulates committee members.
PraxisUnico: Welcomes new committee members
4 November 2011
PraxisUnico warmly welcome new committee members to its Conference and Member Service Committees.
PraxisUnico: Spinouts UK Survey second Quarterly Journal
1 November 2011
The PraxisUnico Spinouts UK Survey second Quarterly Journal contains a mix of news, facts, figures, and analysis of interest.
Isis Innovation: Oxford company raises £3m to commercialise predictive cancer biomarkers
24 January 2012
Treating only patients who are likely to benefit from anti-cancer drugs and identifying quickly which treatment is best for each person, is the aim behind a new spin-out from the University of Oxford, Oxford Cancer Biomarkers Limited (OCB).
Cambridge partnering with Eli Lilly in Open Innovation Drug Discovery Platform
12 January 2012
The University of Cambridge is partnering with Eli Lilly and Company in an active collaboration programme helping to find and develop potential new medicines, particularly in the areas of greatest need.
Inteum Company - new Director of Business Development
12 January 2012
Inteum Company announces Ms. Hope Hartman as their new Director of Business Development.
CRT and Cancer Research UK establish Lipid Metabolism Research Team
16 December 2011
Cancer Research Technlolgy (CRT) – Cancer Research UK’s commercial arm – has established a group of scientists with expertise in lipid metabolism – getting energy from fats and making building blocks for cell growth – to develop targets for potential new cancer drugs.
CRT appoints new Chairman to its Board of Directors
16 December 2011
Cancer Research Technology – the commercial arm of Cancer Research UK – today (Thursday) announced the appointment of Peter Chambré as its new chairman.
Sector
PraxisUnico is an educational not-for-profit organisation set up to support innovation and commercialisation of public sector and charity research for social and economic impact.
PraxisUnico encourages innovation and acts as a voice for the research commercialisation profession, facilitating the interaction between the public sector research base, business and government. PraxisUnico provides a forum for best practice exchange, underpinned by first-class training and development programmes.
